-
5 days ago | 
poz.com | Liz Highleyman
New HIV diagnoses rose by about 1,000 cases nationwide in 2023, according to thelatest surveillance reportfrom the Centers for Disease Control and Prevention (CDC). These data, however, do not yet reflect the effects of the Trump administration’s recent federal health cuts, and advocates fear numbers will rise further in the future.
-
6 days ago | 
tusaludmag.com | Liz Highleyman
In a long-awaited update, the Centers for Disease Control and Prevention (CDC) issued new guidelines for HIV post-exposure prophylaxis (PEP) on May 6. The new guidance—the first revision since 2016—now includes more modern antiretrovirals taken for a month after non-occupational exposure, such as sex or injection drug use.
-
1 week ago | 
poz.com | Liz Highleyman
In a long-awaited update, the Centers for Disease Control and Prevention (CDC) issued new guidelines for HIV post-exposure prophylaxis (PEP) on May 6. The new guidance—the first revision since 2016—now includes more modern antiretrovirals taken for a month after non-occupational exposure, such as sex or injection drug use.
-
1 week ago | 
realhealthmag.com | Liz Highleyman
In a long-awaited update, the Centers for Disease Control and Prevention (CDC) issued new guidelines for HIV post-exposure prophylaxis (PEP) on May 6. The new guidance—the first revision since 2016—now includes more modern antiretrovirals taken for a month after non-occupational exposure, such as sex or injection drug use.
-
1 week ago | 
poz.com | Liz Highleyman
A single dose of the human papillomavirus (HPV) vaccine appears to provide as much protection as the currently recommended two doses for adolescents, according to findings from a nearly five-year study presented at the American Association for Cancer Research annual meeting (AACR 2025). A simpler schedule could encourage higher vaccination rates in the United States and worldwide.
-
1 week ago | 
realhealthmag.com | Liz Highleyman
A single dose of the human papillomavirus (HPV) vaccine appears to provide as much protection as the currently recommended two doses for adolescents, according to findings from a nearly five-year study presented at the American Association for Cancer Research annual meeting (AACR 2025). A simpler schedule could encourage higher vaccination rates in the United States and worldwide.
-
1 week ago | 
hepmag.com | Liz Highleyman
Treatment of metabolic dysfunction-associated steatohepatitis (MASH) may soon be added to the growing list of indications for GLP-1 agonists such as semaglutide (sold as Ozempic and Wegovy). Some experts, however, stress that liver-directed medications are still needed for people with fibrosis or cirrhosis.
-
2 weeks ago | 
poz.com | Liz Highleyman
Body mass index (BMI) alone may be a poor measure of cardiovascular disease risk in people living with HIV, underscoring the importance of screening for excess visceral abdominal fat, according to research presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). People with HIV are at greater risk for heart disease compared with the population at large. Weight gain, a known predictor of cardiovascular disease, is a growing problem among HIV-positive people.
-
2 weeks ago | 
cancerhealth.com | Liz Highleyman
Nearly three quarters of non-small-cell lung cancer (NSCLC) patients with HER2 mutations experienced tumor regression when treated with zongertinib, a novel targeted therapy, according to results from the main cohort of an early study presented at the American Association for Cancer Research annual meeting (AACR 2025) and published in The New England Journal of Medicine.
-
2 weeks ago | 
poz.com | Liz Highleyman
Most people with mismatch repair deficient (dMMR) cancers who used the checkpoint inhibitor Jemperli (dostarlimab) were able to forego surgery and maintain their quality of life, according to study results presented this week at the American Association for Cancer Research annual meeting (AACR 2025) and published in The New England Journal of Medicine.
